Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine whether huperzine A, donepezil, and
galantamine impact militarily relevant aspects of neurocognitive performance in humans,
compared to placebo.
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command